Research by the same group revealed that further modification of these dendrimers with the RGDK peptide allows for selective targeting of ανβ3 integrin and neuropilin-1 (Nrp-1) receptors, which are overexpressed on tumor cells, and effectively prevents tumor cell proliferation in a PC-3 xenograft mouse model [81]. This evidence concerns the gene NRP1 and neoplasm.